Karen A. Briggs
FDA Investigator
- Karen A. Briggs first started conducting FDA inspections in 2021, with the last inspection in 2024. Over that time, Karen A. Briggs has conducted 23 inspections at 23 companies across 23 sites.
Get Karen Briggs's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.
Documents
Upon purchase, you will receive an email with a link to immediately download the documents.
FDA 483 Jiangsu Lianhuan Pharmaceutical Co., Ltd, Yangzhou | 2024
Out of stock
FDA 483 Hisun Pharmaceutical (Nantong) Co., Ltd., Nantong | 2024
Out of stock
FDA 483 Pace Analytical Services, Williamsport | 2024
Out of stock
FDA 483 Hebei Shengxue Dacheng Pharmaceutical Co., Ltd., Shijiazhuang | 2024
Out of stock
FDA 483 Tianjin Jinjin Pharmaceutical Co. Ltd., Xiqing Economic | 2024
Out of stock
FDA 483 Tianjin Darentang Jingwanhong Pharmaceutical Co., Ltd., Tianjin | 2024
Out of stock
FDA 483 Granules Pharmaceuticals Inc., Chantilly | 2021
Out of stock
Co-Investigators (18)
- Dorothy P. Kramer, FDA Investigator
- Johnny D. Nwankwo, FDA Investigator
- Nelson N. Ayangho, FDA Investigator
- Elena N. Thomas, FDA Investigator
- Evan Tong, FDA Investigator
- Brandy N. Lepage, FDA Investigator
- Paige R. Mccoy, FDA Investigator
- Michael O. Idowu, FDA Investigator
- Catherine O. Lamptey, FDA Investigator
- Sean R. Marcsisin, FDA Investigator
- Rachael O. Oyewole, FDA Investigator
- Kristina L. Conroy, FDA Investigator
- Amy N. Chen, FDA Investigator
- Sena G. Dissmeyer, FDA Investigator
- Junho Pak, FDA Investigator
- Jessica S. Estriplet, FDA Investigator
- Tekalign Wondimu, FDA Investigator
- Michele Gottshall, FDA Investigator